Fresh analysis indicates that individuals who come off popular weight-loss injections like semaglutide or tirzepatide may regain shed pounds much more quickly than those who end conventional diet and exercise regimens.
Published data in a major health publication points out that while overweight individuals can lose substantial amounts of their total mass while undergoing treatment, the weight returns at an estimated rate of nearly a kilo each month once they quit.
"Users buying these medications should be cognizant of the danger of rapid rebound weight gain when the treatment concludes," stated expert Dr. Susan Jebb.
Such speed of regain means a reversion to original weight within about one and a half years.
Comparing Therapies
The study, which looked at dozens of studies involving thousands of participants, compared the results of the injectable medications with other pills.
Scientists point out that individuals who shed pounds through dieting typically have a more gradual creep back—approximately 100 grams monthly—post-intervention.
Explaining the Quick Rebound
Experts suggest the way of the jabs is key to understanding the amplified regain.
The injections imitate a body's own chemical called GLP-1, which helps regulate feelings of fullness.
"Long-term administration of GLP-1 concentrations far above than normal might result in the system to generate a reduced amount of its endogenous GLP-1, and could reduce sensitivity to its effects," said Dr. Adam Collins, a dietetics researcher.
"Withdrawal of this hormone supplement results in appetite is uncontrolled, making binge eating much more probable."
A Chronic Issue?
Health authorities advise the jabs for individuals with weight-linked medical conditions, accompanied by prescribed diet and exercise modifications.
Professionals say that, considering the likelihood of weight regain, the therapy should be considered long-term.
This perspective is echoed by pharmaceutical companies, who say that the findings "highlight the chronic nature of excess weight," akin to managing diseases like high blood pressure.
User Testimonies
Individuals who have stopped the medication explain a intense resurgence of cravings.
"It was like a switch activating and you become starving," recalled one woman.
The struggle is compounded if users have not established sustainable lifestyle or habit changes during therapy.
Significant Use
Figures suggest that a significant number of adults in the UK have used weight-loss jabs in the last 12 months, with interest being substantial.
- Adoption is more common among females than males.
- The middle-aged demographic shows the highest usage rates.
- A large proportion access the medications through private prescriptions rather than the NHS.
Finally, experts caution that while these medications are potent tools for shedding pounds, they are not a standalone fix and long-term success likely depends on ongoing lifestyle management.
